Università Vita-Salute San Raffaele
🇮🇹Italy
Clinical Trials
82
Active:3
Completed:32
Trial Phases
4 Phases
Phase 1:1
Phase 3:8
Phase 4:11
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (58 trials with phase data)• Click on a phase to view related trials
Not Applicable
38 (65.5%)Phase 4
11 (19.0%)Phase 3
8 (13.8%)Phase 1
1 (1.7%)Characterization of the Natural History of LAMA2-RD and Identification of Novel Disease Biomarkers
Recruiting
- Conditions
- LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)Merosin Deficient Congenital Muscular DystrophyLAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\)Merosin Deficient CMD (Full or Partial)
- First Posted Date
- 2025-08-15
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- Università Vita-Salute San Raffaele
- Target Recruit Count
- 45
- Registration Number
- NCT07125040
- Locations
- 🇮🇹
Irccs Ospedale San Raffaele, Milan, Italy
Exploring the Relationship Between Social Expertise and Ability to Process Different Types of Abstract Concepts and the Neural Resources Allocated to Their Processing
Not Applicable
Not yet recruiting
- Conditions
- Healthy
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Università Vita-Salute San Raffaele
- Target Recruit Count
- 84
- Registration Number
- NCT07112027
- Locations
- 🇮🇹
Centro Eccellenza Risonanza Magnetica ad Alto Campo (CERMAC), Milano, MI, Italy
Ketamine Augmentation of ECT in Treatment-Resistant Depression
Not Applicable
Recruiting
- Conditions
- Major Depressive DisorderTreatment Resistant Depression
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-07-28
- Last Posted Date
- 2025-07-29
- Lead Sponsor
- Università Vita-Salute San Raffaele
- Target Recruit Count
- 30
- Registration Number
- NCT07088380
- Locations
- 🇮🇹
IRCCS Ospedale San Raffaele Turro, Milan, Italy
Reading-FREE Markers for Early Detection of Developmental Dyslexia
Not Applicable
- Conditions
- Preterm BirthDevelopmental Dyslexia
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Università Vita-Salute San Raffaele
- Target Recruit Count
- 45
- Registration Number
- NCT07072104
- Locations
- 🇮🇹
Neuroradiology Unit and CERMAC, IRCCS Ospedale San Raffaele, Milano, MI, Italy
Photon Counting Computed Tomography in Heart Failure Patients
Not yet recruiting
- Conditions
- Heart Failure
- First Posted Date
- 2025-05-09
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Università Vita-Salute San Raffaele
- Target Recruit Count
- 150
- Registration Number
- NCT06964672
- Prev
- 1
- 2
- 3
- 4
- 5
- 17
- Next
News
Novel BTK Degrader BGB-16673 Achieves 84.8% Response Rate in Heavily Pretreated CLL/SLL Patients
BGB-16673, a novel BTK protein degrader, demonstrated an 84.8% overall response rate in 66 heavily pretreated patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma in the phase 1/2 CaDAnCe-101 trial.